HLB Pharmaceutical CEO · 1 stock
No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.
Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.